The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol
Simon Shorvon,Monica Ferlisi +1 more
Reads0
Chats0
TLDR
There is an urgent need for the establishment of a database of outcomes of individual therapies for super-refractory status epilepticus, which is an uncommon but important clinical problem with high mortality and morbidity rates.Abstract:
Super-refractory status epilepticus is defined as status epilepticus that continues or recurs 24 h or more after the onset of anaesthetic therapy, including those cases where status epilepticus recurs on the reduction or withdrawal of anaesthesia. It is an uncommon but important clinical problem with high mortality and morbidity rates. This article reviews the treatment approaches. There are no controlled or randomized studies, and so therapy has to be based on clinical reports and opinion. The published world literature on the following treatments was critically evaluated: anaesthetic agents, anti-epileptic drugs, magnesium infusion, pyridoxine, steroids and immunotherapy, ketogenic diet, hypothermia, emergency resective neurosurgery and multiple subpial transection, transcranial magnetic stimulation, vagal nerve stimulation, deep brain stimulation, electroconvulsive therapy, drainage of the cerebrospinal fluid and other older drug therapies. The importance of treating the identifying cause is stressed. A protocol and flowchart for managing super-refractory status epilepticus is suggested. In view of the small number of published reports, there is an urgent need for the establishment of a database of outcomes of individual therapies.read more
Citations
More filters
Journal ArticleDOI
Deep brain stimulation in critical care conditions.
Angelo Franzini,Roberto Cordella,Michele Rizzi,Carlo Efisio Marras,Giuseppe Messina,Giovanna Zorzi,Dario Caldiroli +6 more
TL;DR: In this paper, a before-and-after perspective study was examined of seven patients who were treated with DBS for status dystonicus (SD) and post-stroke severe hemiballismus.
Journal ArticleDOI
Making SENSE - Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry
Christoph Kellinghaus,Nicolas Lang,Andrea O. Rossetti,Stephan Rüegg,Christian Tilz,Eugen Trinka,Iris Unterberger,Zeljko Uzelac,Felix Rosenow +8 more
TL;DR: A prospective multicenter observational registry for patients treated for status epilepticus, aiming to document patient characteristics, treatment modalities and in-house outcome of consecutive adults admitted for SE treatment in each of the participating centres and to identify predictors of outcome.
Journal ArticleDOI
The historical evolution of, and the paradigms shifts in, the therapy of convulsive status epilepticus over the past 150 years
TL;DR: The evolution of the treatment of convulsive status epilepticus since the mid‐ nineteenth century is outlined and changes to the approach to therapy have been more important than any pharmacologic advance and the authors may be on the threshold of significant new paradigm shifts.
Journal ArticleDOI
Effect of thymectomy on refractory autoimmune status epilepticus.
Alberto Vogrig,Giada Pauletto,Enrico Belgrado,Enrico Pegolo,Carla Di Loreto,Véronique Rogemond,Jérôme Honnorat,Roberto Eleopra +7 more
TL;DR: This is the first report of successful treatment of RSE with tumor removal in paraneoplastic encephalitis and the effect of thymectomy on seizure outcome.
Journal ArticleDOI
A Study of Super Refractory Status Epilepticus from India.
TL;DR: The frequency, etiology and outcome of Super refractory status epilepticus (SRSE) are reported in patients with consecutive patients with SRSE during 2013 to 2016 and the patients with treatable etiology had a better outcome.
References
More filters
Journal ArticleDOI
Magnesium gates glutamate-activated channels in mouse central neurones
TL;DR: The voltage dependence of the NMDA receptor-linked conductance appears to be a consequence of the voltage dependenceof the Mg2+ block and its interpretation does not require the implication of an intramembrane voltage-dependent ‘gate’.
Journal ArticleDOI
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
Mattia Maroso,Silvia Balosso,Teresa Ravizza,Jaron Liu,Eleonora Aronica,Anand Iyer,Carlo Rossetti,Carlo Rossetti,Monica Molteni,Maura Casalgrandi,Angelo A. Manfredi,Marco Bianchi,Annamaria Vezzani +12 more
TL;DR: HMGB1-TLR4 signaling may contribute to generating and perpetuating seizures in humans and might be targeted to attain anticonvulsant effects in epilepsies that are currently resistant to drugs.
Journal Article
Which anticonvulsant for women with eclampsia - evidence from the collaborative eclampsia trial
Lelia Duley,Guillermo Carroli,José M. Belizán,L Gonzalez,Liana Campodonico,Eduardo Bergel,P Taillades,Sarah Ayers,L Wincott,K Gallagher,K Fredrick,J Reynolds,S Adadevoh,Álvaro Nagib Atallah,K George,Adrian Grant,K Mahomed,S Mehta,F Mmiro,Jack Moodley,James P Neilson,S Sheth,Godfrey Ja Walker,Iain Chalmers,Rory Collins,S.P. Munjanja,Christopher W.G. Redman,Diana Elbourne +27 more
Journal ArticleDOI
Refractory Status Epilepticus: Frequency, Risk Factors, and Impact on Outcome
Stephan A. Mayer,Jan Claassen,Johnny Lokin,Felicia A. Mendelsohn,Lyle J. Dennis,Brian-Fred Fitzsimmons +5 more
TL;DR: Refractory status epilepticus occurs in approximately 30% of patients with SE and is associated with increased hospital length of stay and functional disability, and nonconvulsive SE and focal motor seizures at onset are risk factors for RSE.
The treatment of convulsive status epilepticus, recommendations of the epilepsy foundation of america’s working group on status epilepticus
TL;DR: Common to all patients is the need for a clear plan, prompt administration of appropriate drugs in adequate doses, and attention to the possibility of apnea, hypoventilation, or other metabolic abnormalities.